Get started
Author

Anne Hendrickx

Observed names: A Hendrickx, A. Hendrickx, Hendrickx, Anne
Observed institution: Intermutualist Agency
ORCID: 0000-0001-5433-3650
Observed ORCID: 0000-0001-5433-3650
OpenAlex ID: A5062762831
Ein transparentes Modell für einen fairen Preis für innovative Arzneimittel in Europa
2021 · Anne Hendrickx, Thomas Kanga-Tona · Springer eBooks · 3
PDF
Principles of selecting cost-effectiveness thresholds in price-taker countries
2026 · Zoltán Kaló, Maureen Rutten-van Mölken, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
PDF
ACCESS2MEDS Framework
2026 · Emily Burger, Benjamin P. Geisler, et al. · OSF Preprints (OSF Preprints)
Market Entry Agreements for Innovative Pharmaceuticals Subject to Indication Broadening: A Case Study for Pembrolizumab in The Netherlands
2026 · Yansi Wu, Maureen Rutten-van Mölken, et al. · OSF Preprints (OSF Preprints)
Bridging affordability and sustainability of health innovations via novel pricing, cost-effectiveness, and reimbursement models to improve patient access: The ASCERTAIN project
2026 · Carin A. Uyl-de Groot, Nicolas S.H. Xander, et al. · Health Policy and Technology
HPR129 Introducing an Access-Based Pricing Model to Determine Prices and Inform Price Negotiations for Newly Authorized Medicinal Products
2025 · Nicolas S.H. Xander, Maximilian Salcher-Konrad, et al. · Value in Health
Price determinants and pricing policies concerning potentially innovative health technologies: a scoping review
2025 · Nicolas S. H. Xander, Tom Belleman, et al. · The European Journal of Health Economics
PDF
Balancing Innovation and Access: Insights from AIM’s Fair Pricing Model and Its Current and Future Applications
2025 · Jocelijn Stokx, Anne Hendrickx, et al. · PharmacoEconomics
PDF
Auf dem Weg zu einer gerechten und nachhaltigen Preisgestaltung im Gesundheitswesen: Fokus auf das AIM-Fair-Price-Modell und das ASCERTAIN-Projekt
2025 · Carin A. Uyl-de Groot, Nicolas S.H. Xander, et al. · Springer eBooks
PDF
HPR46 Exploring Managed Entry Agreements: A Scoping Review of Approaches, Considerations, and Country-Specific Approaches
2024 · T Belleman, N Xander, et al. · Value in Health
PDF
HPR237 Price Determinants and Pricing Policies Concerning Potentially Innovative Health Technologies: A Scoping Review
2024 · N Xander, T Belleman, et al. · Value in Health
PDF
HPR164 What Is a Fair Price? A Review of Definitions for Fair Prices of Health Technologies
2023 · M. Salcher-Konrad, N. Zimmermann, et al. · Value in Health
Fair pricing in drug repurposing
2022 · Anne Hendrickx
PDF
Works count: 17
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type